179 related articles for article (PubMed ID: 32471161)
1. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells.
Tatsumi Y; Miyake M; Shimada K; Fujii T; Hori S; Morizawa Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471161
[TBL] [Abstract][Full Text] [Related]
2. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
3. Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.
Shimada K; Nakamura M; De Velasco MA; Tanaka M; Ouji Y; Miyake M; Fujimoto K; Hirao K; Konishi N
Cancer Sci; 2010 Jan; 101(1):155-60. PubMed ID: 19860843
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design of a selective heparanase inhibitor as an antimetastatic agent.
Ishida K; Hirai G; Murakami K; Teruya T; Simizu S; Sodeoka M; Osada H
Mol Cancer Ther; 2004 Sep; 3(9):1069-77. PubMed ID: 15367701
[TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase.
Yan L; Yan K; Kun W; Xu L; Ma Q; Tang Y; Jiao W; Gu G; Fan Y; Xu Z
Tumour Biol; 2013 Feb; 34(1):215-21. PubMed ID: 23065570
[TBL] [Abstract][Full Text] [Related]
6. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
7. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
Quan Y; Lei H; Wahafu W; Liu Y; Ping H; Zhang X
Biomed Pharmacother; 2019 Dec; 120():109490. PubMed ID: 31574376
[TBL] [Abstract][Full Text] [Related]
9. Involvement of heparanase in migration of microglial cells.
Takahashi H; Matsumoto H; Smirkin A; Itai T; Nishimura Y; Tanaka J
Biochim Biophys Acta; 2008 Apr; 1780(4):709-15. PubMed ID: 18222122
[TBL] [Abstract][Full Text] [Related]
10. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase.
Li Y; Liu H; Huang YY; Pu LJ; Zhang XD; Jiang CC; Jiang ZW
Int J Mol Med; 2013 May; 31(5):1234-42. PubMed ID: 23467544
[TBL] [Abstract][Full Text] [Related]
11. The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
Weissmann M; Bhattacharya U; Feld S; Hammond E; Ilan N; Vlodavsky I
Matrix Biol; 2019 Apr; 77():58-72. PubMed ID: 30096360
[TBL] [Abstract][Full Text] [Related]
12. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.
Purushothaman A; Uyama T; Kobayashi F; Yamada S; Sugahara K; Rapraeger AC; Sanderson RD
Blood; 2010 Mar; 115(12):2449-57. PubMed ID: 20097882
[TBL] [Abstract][Full Text] [Related]
13. Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts.
Kurokawa H; Katsube K; Podyma KA; Ikuta M; Iseki H; Nakajima M; Akashi T; Omura K; Takagi M; Yanagishita M
Cancer Sci; 2003 Mar; 94(3):277-85. PubMed ID: 12824922
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo.
Zuo Y; Xu X; Chen M; Qi L
Cancer Med; 2021 Jul; 10(13):4437-4450. PubMed ID: 34105305
[TBL] [Abstract][Full Text] [Related]
15. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
16. Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells.
Jiang G; Zheng L; Pu J; Mei H; Zhao J; Huang K; Zeng F; Tong Q
PLoS One; 2012; 7(2):e31379. PubMed ID: 22363633
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
18. Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells.
Zheng L; Jiang G; Mei H; Pu J; Dong J; Hou X; Tong Q
BMC Cancer; 2010 Feb; 10():33. PubMed ID: 20137078
[TBL] [Abstract][Full Text] [Related]
19. Exploitation of heparanase inhibitors from microbial metabolites using an efficient visual screening system.
Ishida K; Teruya T; Simizu S; Osada H
J Antibiot (Tokyo); 2004 Feb; 57(2):136-42. PubMed ID: 15112962
[TBL] [Abstract][Full Text] [Related]
20. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
